Literature DB >> 15785300

Fibrinogen and cigarette smoking in men and women in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population.

Shubhada Sinha1, Robert N Luben, Ailsa Welch, Sheila Bingham, Nicholas J Wareham, Nicholas E Day, Kay-Tee Khaw.   

Abstract

BACKGROUND: Plasma fibrinogen may be an independent risk factor for cardiovascular disease. Cigarette smoking is a well-recognized determinant of plasma fibrinogen however it remains unclear how fibrinogen levels relate to the degree and duration of smoking, or to time since smoking cessation.
METHODS: In a population-based study of 11 059 men and women aged 45-74 years, we examined the cross-sectional relationship between plasma fibrinogen and cigarette smoking habit.
RESULTS: Mean fibrinogen concentrations were higher in current smokers compared to non-current smokers (men: 3.13+/-0.77 versus 2.80+/-0.71 g/l, P<0.0001; women: 3.03+/-0.72 versus 2.95+/-0.71 g/l, P=0.01), independent of age, body mass index and hormone replacement therapy in women In men, fibrinogen concentrations declined with years since stopping smoking but remained higher than in life-long non-smokers for 15 years. No relationship between fibrinogen and duration of smoking cessation was observed in women. On multivariate analysis, age, body mass index, use of hormone-replacement therapy, smoking status and pack-years of smoking were independent predictors of plasma fibrinogen.
CONCLUSIONS: Plasma fibrinogen is strongly associated with cigarette smoking with a dose-response relationship with total pack-years of smoking. In men who stop smoking plasma fibrinogen may remain elevated for several years after cessation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15785300     DOI: 10.1097/01.hjr.0000140719.09768.e2

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  7 in total

1.  Modeling the Causal Role of DNA Methylation in the Association Between Cigarette Smoking and Inflammation in African Americans: A 2-Step Epigenetic Mendelian Randomization Study.

Authors:  Min A Jhun; Jennifer A Smith; Erin B Ware; Sharon L R Kardia; Thomas H Mosley; Stephen T Turner; Patricia A Peyser; Sung Kyun Park
Journal:  Am J Epidemiol       Date:  2017-11-15       Impact factor: 4.897

2.  Smoking, fibrinogen and cancer mortality.

Authors:  Charles J Everett; Brian J Wells; Ivar L Frithsen; Richelle J Koopman
Journal:  J Natl Med Assoc       Date:  2007-04       Impact factor: 1.798

3.  Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study.

Authors:  Sara Ahmadi-Abhari; Robert N Luben; Nicholas J Wareham; Kay-Tee Khaw
Journal:  Eur J Epidemiol       Date:  2013-07-03       Impact factor: 8.082

4.  Erectile dysfunction, physical activity and metabolic syndrome: differences in markers of atherosclerosis.

Authors:  Hanna Pohjantähti-Maaroos; Ari Palomäki; Juha Hartikainen
Journal:  BMC Cardiovasc Disord       Date:  2011-06-27       Impact factor: 2.298

5.  No evidence for genome-wide interactions on plasma fibrinogen by smoking, alcohol consumption and body mass index: results from meta-analyses of 80,607 subjects.

Authors:  Jens Baumert; Jie Huang; Barbara McKnight; Maria Sabater-Lleal; Maristella Steri; Audrey Y Chu; Stella Trompet; Lorna M Lopez; Myriam Fornage; Alexander Teumer; Weihong Tang; Alicja R Rudnicka; Anders Mälarstig; Jouke-Jan Hottenga; Maryam Kavousi; Jari Lahti; Toshiko Tanaka; Caroline Hayward; Jennifer E Huffman; Pierre-Emmanuel Morange; Lynda M Rose; Saonli Basu; Ann Rumley; David J Stott; Brendan M Buckley; Anton J M de Craen; Serena Sanna; Marco Masala; Reiner Biffar; Georg Homuth; Angela Silveira; Bengt Sennblad; Anuj Goel; Hugh Watkins; Martina Müller-Nurasyid; Regina Rückerl; Kent Taylor; Ming-Huei Chen; Eco J C de Geus; Albert Hofman; Jacqueline C M Witteman; Moniek P M de Maat; Aarno Palotie; Gail Davies; David S Siscovick; Ivana Kolcic; Sarah H Wild; Jaejoon Song; Wendy L McArdle; Ian Ford; Naveed Sattar; David Schlessinger; Anne Grotevendt; Maria Grazia Franzosi; Thomas Illig; Melanie Waldenberger; Thomas Lumley; Geoffrey H Tofler; Gonneke Willemsen; André G Uitterlinden; Fernando Rivadeneira; Katri Räikkönen; Daniel I Chasman; Aaron R Folsom; Gordon D Lowe; Rudi G J Westendorp; P Eline Slagboom; Francesco Cucca; Henri Wallaschofski; Rona J Strawbridge; Udo Seedorf; Wolfgang Koenig; Joshua C Bis; Kenneth J Mukamal; Jenny van Dongen; Elisabeth Widen; Oscar H Franco; John M Starr; Kiang Liu; Luigi Ferrucci; Ozren Polasek; James F Wilson; Tiphaine Oudot-Mellakh; Harry Campbell; Pau Navarro; Stefania Bandinelli; Johan Eriksson; Dorret I Boomsma; Abbas Dehghan; Robert Clarke; Anders Hamsten; Eric Boerwinkle; J Wouter Jukema; Silvia Naitza; Paul M Ridker; Henry Völzke; Ian J Deary; Alexander P Reiner; David-Alexandre Trégouët; Christopher J O'Donnell; David P Strachan; Annette Peters; Nicholas L Smith
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

6.  The incidence and risk factors of deep venous thrombosis in lower extremities following surgically treated femoral shaft fracture: a retrospective case-control study.

Authors:  Zhixin Ren; Yufei Yuan; Wei Qi; Yanbao Li; Pengcheng Wang
Journal:  J Orthop Surg Res       Date:  2021-07-09       Impact factor: 2.359

7.  Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both.

Authors:  Jordi Olloquequi; Sergio Jaime; Viviana Parra; Elizabeth Cornejo-Córdova; Gonzalo Valdivia; Àlvar Agustí; Rafael Silva O
Journal:  Respir Res       Date:  2018-01-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.